Novartis Ag Stock Price Patterns

Intrinsic Valuation Low Real High 114.40 117.30 174.36 Details

Naive Forecast Low Next High 158.93 161.83 164.74 Details

Bollinger Band Projection (param) Lower Middle Band Upper 150.42 156.46 162.51 Details

Novartis After-Hype Price Density Analysis

Novartis Estimiated After-Hype Price Volatility

Novartis Pink Sheet Price Outlook Analysis

Notes

Novartis Hype Timeline

Novartis AG is now traded for 158.51. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Novartis is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at 0.42%. %. The volatility of related hype on Novartis is about 9.223372036854776E16%, with the expected price after the next announcement by competition of 158.51. About 34.0% of the company shares are owned by institutional investors. The book value of Novartis was now reported as 28.0. The company last dividend was issued on the 9th of March 2023. Novartis AG had 40:1 split on the 7th of May 2001. Assuming the 90 days horizon the next forecasted press release will be uncertain. Check out Novartis Basic Forecasting Models to cross-verify your projections.

Novartis Related Hype Analysis

Novartis Additional Predictive Modules

Most predictive techniques to examine Novartis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Novartis using various technical indicators. When you analyze Novartis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Novartis stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Novartis AG, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Novartis based on analysis of Novartis hews, social hype, general headline patterns, and widely used predictive technical indicators.

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.